Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme

NCT00112502 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

178

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors
Glioblastoma Multiforme

Interventions

DRUG: Celecoxib
DRUG: Isotretinoin
DRUG: Temozolomide
DRUG: Thalidomide

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]